Marché des antibiotiques à base de carbapénème – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00027228
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

La taille du marché des antibiotiques à base de carbapénème devrait passer de 3 964,57 millions de dollars US en 2021 à 5 346,62 millions de dollars US d'ici 2028 ; on estime qu'il augmentera à un TCAC de 4,4 % entre 2021 et 2028.

Les carbapénèmes sont un type d'antibiotiques bêta-lactamines atypiques qui ont une activité antibactérienne plus large. Les antibiotiques à base de carbapénème peuvent lutter contre de nombreuses bactéries aérobies et anaérobies à Gram positif, à Gram négatif. De plus, les antibiotiques à base de carbapénème sont stables vis-à-vis de la plupart des bêta-lactamases. Par conséquent, ils sont indiqués en monothérapie empirique pour diverses affections graves, telles que les infections neutropéniques et les infections intra-abdominales.

Aperçus stratégiques


La prévalence croissante Les infections bactériennes à Gram négatif et la production croissante de médicaments génériques alimentent la croissance du marché des antibiotiques à base de carbapénème. Cependant, le processus fastidieux et coûteux de développement d’antibiotiques freine la croissance du marché.

Marché mondial des antibiotiques à base de carbapénème

< p>

Aperçu du marché
Prévalence croissante des infections bactériennes à Gram négatif

Infections bactériennes à Gram négatif, telles que les infections des voies urinaires (IVU), la pneumonie, les infections du sang, les infections des plaies ou du site opératoire et la méningite sont généralement contractées par les patients au cours de leur séjour à l'hôpital. Ces infections sont généralement connues sous le nom d’infections nosocomiales (IAS). Les infections telles que les infections urinaires et la pneumonie sont fréquentes chez les patients admis dans les unités de soins intensifs. Selon le National Healthcare Safety Network des États-Unis, 30 % des IAS sont causées par des bactéries à Gram négatif, environ 45 % sont dues à une infection urinaire et environ 47 % sont dues à une pneumonie nosocomiale (PAV). La prévalence des maladies infectieuses causées par des bactéries Gram-négatives augmente rapidement.

En outre, les infections bactériennes Gram-négatives sont résistantes à plusieurs médicaments et ont développé une meilleure résistance aux médicaments disponibles. antibiotiques. La résistance aux antimicrobiens (RAM) est devenue une menace mondiale pour la médecine moderne. Par conséquent, une surveillance constante des tendances émergentes est nécessaire pour les isolats cliniques. Un groupe de chercheurs en Lettonie, en Europe, a étudié la progression de la RAM pour différentes bactéries à Gram négatif. Selon l'article de recherche qu'ils ont publié dans la revue MDPI en juin 2021, les antibiotiques à base de carbapénème tels que le méropénème et l'ertapénème étaient les plus efficaces contre les bactéries à Gram négatif, affichant respectivement des taux de résistance de 3 % et 5,4 %. Ces antibiotiques sont mondialement acceptés comme traitement contre les bactéries à Gram négatif. Par conséquent, on estime que la forte demande d'antibiotiques à base de carbapénème devrait se poursuivre dans les années à venir.

Selon les Centers for Disease Control and Prevention (CDC) , la pandémie de COVID-19 a entraîné une augmentation des cas d’IAS en 2020. Les admissions à l’hôpital ont augmenté à l’échelle mondiale, ce qui a augmenté le risque de PAV en tant qu’infection secondaire pour les patients atteints de COVID-19. Cela a entraîné une demande accrue d'antibiotiques à base de carbapénème, ce qui aide considérablement le marché.

Informations basées sur les types

Les antibiotiques à base de carbapénème Le marché des antibiotiques, par type, est segmenté en méropénème, doripénème, imipénème, tébipénème et autres. Les autres segments détenaient la plus grande part du marché des antibiotiques à base de carbapénème en 2021, et il devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. Les développements croissants dans le domaine des antibiotiques à base de carbapénème sont susceptibles de stimuler la croissance du marché à l'avenir.

Part de marché des antibiotiques à base de carbapénème, par type - 2021 et 2028

Informations basées sur les indications

Par indication, le Le marché des antibiotiques à base de carbapénème est segmenté en méningite bactérienne, infections pelviennes aiguës, infections des voies respiratoires, infections intra-abdominales, infections des voies urinaires et autres. Les autres segments détenaient la plus grande part du marché des antibiotiques à base de carbapénème en 2021, et on estime qu’il enregistrera le TCAC le plus élevé du marché au cours de la période de prévision. L'incertitude liée aux infections bactériennes stimule la demande d'antibiotiques à base de carbapénème, ce qui devrait stimuler la croissance du marché dans les années à venir.

Informations basées sur les canaux de distribution< /h3>

Par canal de distribution, le marché des antibiotiques à base de carbapénème est segmenté en pharmacies de détail, pharmacies en ligne et pharmacies hospitalières. Le segment des pharmacies hospitalières détenait la plus grande part du marché des antibiotiques à base de carbapénème en 2021, et on estime qu'il enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.

 

Les stratégies organiques, telles que le lancement de nouveaux produits, sont couramment adoptées par les entreprises pour élargir leur portefeuille de produits sur le marché. De plus, les entreprises ont mis en œuvre diverses stratégies inorganiques, telles que des fusions et acquisitions et des partenariats. Par exemple, en mai 2021, Gland Pharma Limited, en association avec Dr Reddy's Laboratories Ltd, a lancé l'ertapénem pour injection, 1 g/flacon, un équivalent thérapeutique à la version générique d'INVANZ (ertapénem pour injection) pour injection) 1 g/flacon, qui est approuvé par la Food and Drug Administration des États-Unis (USFDA).

Profils d'entreprises

  • Pfizer Inc.
  • Savior Lifetec
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Merck & Co., Inc.
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • DAEWOONG PHARMACEUTICAL CO.,LTD
  • Iterum Therapeutics plc
  • li>
  • ACS Dobfar SpA
  • Spero Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the carbapenem-based antibiotics?

Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.

What are the driving factors for the global carbapenem-based antibiotics market across the world?

The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.

Who are the major players in market the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.

Which segment is dominating the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.

The List of Companies - Carbapenem Based Antibiotics Market

  1. Pfizer Inc.
  2. Savior Lifetec
  3. Sumitomo Dainippon Pharma Co., Ltd.
  4. Merck & Co., Inc.
  5. Gland Pharma Limited
  6. Aurobindo Pharma Ltd
  7. Daewoong Pharmaceutical Co.,Ltd,
  8. Iterum Therapeutics plc
  9. ACS Dobfar S.p.A
  10. Spero Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports